Haba A - Search Results

1

Analysis of cytotoxic activity of the CD4+ T lymphocytes generated by local immunotherapy.

Katsumoto Y, Monden T, Takeda T, Haba A, Ito Y, Wakasugi E, Wakasugi T, Sekimoto M, Kobayashi T, Shiozaki H, Shimano T, Monden M. Katsumoto Y, et al. Among authors: haba a. Br J Cancer. 1996 Jan;73(1):110-6. doi: 10.1038/bjc.1996.20. Br J Cancer. 1996. PMID: 8554971 Free PMC article.

2

PyNPase expression in human colon cancer.

Haba A, Monden T, Sekimoto M, Ikeda K, Izawa H, Kanou T, Amano M, Kan'yama H, Monden M. Haba A, et al. Cancer Lett. 1998 Jan 9;122(1-2):85-92. doi: 10.1016/s0304-3835(97)00375-3. Cancer Lett. 1998. PMID: 9464495

3

Selective augmentations of intratumoral 5-fluorouracil concentration by local immunotherapy with OK-432 and fibrinogen.

Amano M, Sekimoto M, Monden T, Tomita N, Ohue M, Haba A, Sakita I, Tamaki Y, Monden M. Amano M, et al. Among authors: haba a. Dis Colon Rectum. 2000 Mar;43(3):402-7. doi: 10.1007/BF02258309. Dis Colon Rectum. 2000. PMID: 10733124 Clinical Trial.

4

Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections.

Ikeda K, Monden T, Kanoh T, Tsujie M, Izawa H, Haba A, Ohnishi T, Sekimoto M, Tomita N, Shiozaki H, Monden M. Ikeda K, et al. Among authors: haba a. J Histochem Cytochem. 1998 Mar;46(3):397-403. doi: 10.1177/002215549804600314. J Histochem Cytochem. 1998. PMID: 9487122

5

[Successful immunotherapy combined with hyperthermia therapy for cancer patients].

Takeda T, Dong X, Takeda H, Haba A, Takeda Y. Takeda T, et al. Among authors: haba a. Gan To Kagaku Ryoho. 2006 Nov;33(12):1739-41. Gan To Kagaku Ryoho. 2006. PMID: 17212092 Japanese.

6

[PyNPase expression and cancer progression in the colorectum].

Monden T, Haba A, Amano M, Kanoh T, Tsujie M, Ikeda K, Izawa H, Ohnishi T, Sekimoro M, Tomita N, Okamura J, Monden M. Monden T, et al. Among authors: haba a. Nihon Geka Gakkai Zasshi. 1998 Jul;99(7):446-51. Nihon Geka Gakkai Zasshi. 1998. PMID: 9742526 Review. Japanese.

7

[Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients].

Takeda T, Dong X, Takeda H, Haba A, Takeda Y. Takeda T, et al. Among authors: haba a. Gan To Kagaku Ryoho. 2007 Nov;34(12):1905-7. Gan To Kagaku Ryoho. 2007. PMID: 18219848 Japanese.

8

[Intratumoral injection of immature dendritic cells (DC) for cancer patients].

Takeda T, Makita K, Okita K, Haba A, Xianhui D. Takeda T, et al. Among authors: haba a. Gan To Kagaku Ryoho. 2005 Oct;32(11):1574-5. Gan To Kagaku Ryoho. 2005. PMID: 16315873 Japanese.

9

Endoglin-targeted cancer therapy.

Seon BK, Haba A, Matsuno F, Takahashi N, Tsujie M, She X, Harada N, Uneda S, Tsujie T, Toi H, Tsai H, Haruta Y. Seon BK, et al. Among authors: haba a. Curr Drug Deliv. 2011 Jan;8(1):135-43. doi: 10.2174/156720111793663570. Curr Drug Deliv. 2011. PMID: 21034418 Free PMC article. Review.

10

Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.

Takahashi N, Haba A, Matsuno F, Seon BK. Takahashi N, et al. Among authors: haba a. Cancer Res. 2001 Nov 1;61(21):7846-54. Cancer Res. 2001. PMID: 11691802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters